NANSIN LTD – Trademark Portfolio

Entity Type: 16

NANSIN LTD holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include DNEG and BOLERBRO. The owner is based in SPOKANE, WA.

100N HOWARD ST STE R

SPOKANE, WA 99201

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BOLERBRO
BOLERBRO
Registered 2023
BOLERBRO
BOLERBRO
Registered 2023
DNEG
DNEG
Registered 2023
DNEG
DNEG
Registered 2023

Trademark Classifications

NANSIN LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does NANSIN LTD have?

NANSIN LTD has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does NANSIN LTD file in?

NANSIN LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are NANSIN LTD's most well-known trademarks?

NANSIN LTD's registered trademark portfolio includes well-known marks such as DNEG and BOLERBRO. These are among 4 currently registered trademarks in the portfolio.

What is NANSIN LTD's trademark registration success rate?

NANSIN LTD has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.